Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-26-028115·Clearmind Medicine Inc.
Schedule 13G ownership disclosure
CLEARMIND MEDICINE INC
Common Shares, no par value per share · CUSIP: 185053402
Event date: 2026-02-09
- Filing-level shares
- 108,720.00
- Percent of class
- 5.0%
- L.I.A. Pure Capital Ltd.
Shares: 108,720.00 · Class: 5.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-028115
- Form type
- SCHEDULE 13G/A
- Filer
- Clearmind Medicine Inc.
- CIK
- CIK 1892500
- Filed
- Mar 16, 2026
- Reporting period
- Feb 09, 2026
- Description
- Schedule 13G beneficial ownership